Norgesic
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a682162 |
| Routes of administration | Oral |
| Identifiers | |
| CAS Number | |
| (verify) | |
Norgesic is the brand name of a muscle relaxant produced by Galt Pharmaceuticals[1]. The generic is a combination of 385 mg of aspirin[2], 25 mg of orphenadrine citrate[2] and 30 mg of caffeine.[3]
It was discontinued in the United States in October 2015[4] but was returned to the United States market in 2022[1] and is still available in Scandinavia, Austria, Greece, Thailand, Australia and Hong Kong. In some countries Norgesic has a different pharmaceutical combination. For example in Greece the combination of 450 mg of aspirin, 35 mg of orphenadrine citrate is common.
References
- ^ a b "DailyMed - NORGESIC- orphenadrine citrate, aspirin and caffeine tablet". dailymed.nlm.nih.gov. Retrieved 2025-06-11.
- ^ a b "Norgesic". drugs.com.
- ^ Haig AJ (2005). Back Pain: A Guide for the Primary Care Physician. Versa Press. p. 151. ISBN 1-930513-59-3.
- ^ "Determination That TENSILON and TENSILON Preservative Free (Edrophonium Chloride) Injectable and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness". Food and Drug Administration, Federal Register Volume 80, # 210. 2015-10-30. Archived from the original on 2017-08-26. Retrieved 2017-08-26.